PEG-Free Shielding Lipids

PEG-Free Shielding Lipids
Product Description

Shielding lipids are key to keeping LNPs stable, long‑circulating, and efficient at delivering RNA or gene‑therapy payloads. As PEG‑based systems face growing concerns due to immunogenicity and accelerated clearance, new PEG‑free strategies are becoming essential for safer and more flexible nanoparticle design.
Curapath offers advanced PEG‑free shielding lipids that preserve steric stabilization while improving in vivo performance, storage stability, and formulation versatility. Combined with CliCr® conjugation, Curapath enables precise attachment of targeting ligands—such as peptides or antibodies—supporting tissue‑specific delivery for applications including T‑cell, lung, and CNS targeting.
You can find all the information here:PEG-Free Shielding Lipids for Advanced LNP Development | Curapath

Read more Show less

Curapath

  • Country/Region:
    Spain
  • On CPHI since:
    2023
  • Certificates:
    2
  • Employees:
    50 - 99
Company types
CMO/CDMO
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Primary activities
Analytical Services
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Intermediates Manufacturer
Medical Devices
View company profile
Categories
more categories Show less

Curapath

  • Country/Region:
    Spain
  • On CPHI since:
    2023
  • Certificates:
    2
  • Employees:
    50 - 99
Company types
CMO/CDMO
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Primary activities
Analytical Services
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Intermediates Manufacturer
Medical Devices
View company profile

More Products from Curapath (8)

  • Bioconjugation

    Product Bioconjugation

    Polymer bioconjugation offers powerful strategies to extend half-life, improve stability, and enable encapsulation of therapeutic molecules. By conjugating polymers to proteins, peptides, or other actives, it is possible to enhance pharmacokinetics, reduce immunogenicity, and unlock new delivery pathways. ...
  • Custom polymers and lipids

    Product Custom polymers and lipids

    Custom polymers and lipids enable the creation of tailored delivery systems that meet the unique requirements of each therapeutic program. At Curapath, we support our partners with bespoke synthesis and design, offering flexibility in polymer architecture, lipid structures, functionalization, and scale. Th...
  • ionizable lipids

    Product ionizable lipids

    Ionizable lipids are key components in LNP formulations, enabling efficient RNA encapsulation and protection, while ensuring intracellular release through their pH-dependent charge switch. This unique property makes them essential for the safe and effective delivery of nucleic acid-based therapeutics. At ...
  • Ready-to-use formulations

    Product Ready-to-use formulations

    Ready-to-use formulations simplify development by providing immediate access to well-characterized LNP systems. At Curapath, we offer a spectrum ranging from standard reference formulations to custom-designed systems, where we combine our proprietary shielding lipids with innovative ionizable lipids. This ...
  • Shielding lipids

    Product Shielding lipids

    Shielding lipids play a crucial role in prolonging circulation time and enhancing the stability of LNPs by preventing opsonization and rapid clearance. Traditionally, PEG-lipids have been used for this purpose, but concerns around immunogenicity and tolerability have driven the search for better solutions....
  • Formulation Development Services for Lipid & Polymer Nanoparticles

    Product Formulation Development Services for Lipid & Polymer Nanoparticles

    Curapath offers a tiered suite of Formulation Development Packages to accelerate LNP and PNP development for nucleic acid and peptide delivery, with Essential, Advanced, and Expert options that increase in complexity, analytical depth, and formulation flexibility. These packages cover formulation‑screening...
  • PSar‑based solubilizing agent

    Product PSar‑based solubilizing agent

    Biologic formulations often struggle with protein aggregation, immunogenicity, and limited shelf life, while polysorbates can degrade in aqueous environments and trigger PEG‑related reactions; PSar‑based solubilizing agents offer a next‑generation alternative that improves stability, enhances solubility at...
  • Solutions for PLA/PLGA API Encapsulation

    Product Solutions for PLA/PLGA API Encapsulation

    Curapath introduces a structured suite of Formulation Development Packages designed to streamline the creation and optimization of PLA/PLGA‑based nanoparticles for peptides and small molecules, offering three scalable levels of support: the Essential package focuses on rapid development of PLA/PLGA + API n...

Curapath resources (35)